• Mar 10, 2025

3 Reasons to Sell DVA and 1 Stock to Buy Instead

Since September 2024, DaVita has been in a holding pattern, posting a small loss of 4.3% while floating around $147.02. The stock also fell short of the S&P 500’s 3.7% gain during that period.

  • Mar 10, 2025

3 Reasons to Avoid ABT and 1 Stock to Buy Instead

Abbott Laboratories’s 16.6% return over the past six months has outpaced the S&P 500 by 12.8%, and its stock price has climbed to $136.50 per share. This run-up might have investors contemplating their next move.